Date Title Statement Presentation Report Webcast
7 September 2017

Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

  Presentation    
14 August 2017

Investor presentation, August 2017

  Presentation    
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us